Class II
Terminated
Exaprin pain reliever (acetaminophen 110 mg, aspirin 162 mg, caffeine 32.4mg, salicylamide 152mg) tablets, 2- tablet packets, Manufactured for: HARTHealth Seattle, WA 98124
Why: cGMP deviations
- Company
- Ultra Seal Corporation
New Paltz, NY, United States - Reported
- Feb 9, 2022
- Recall started
- Jan 24, 2022
- Ended
- Oct 16, 2023
- Where sold
- Nationwide within the United States
- Amount
- 1,1401,641 packets
- Full product description
- Exaprin pain reliever (acetaminophen 110 mg, aspirin 162 mg, caffeine 32.4mg, salicylamide 152mg) tablets, 2- tablet packets, Manufactured for: HARTHealth Seattle, WA 98124
- Lots / codes affected
- Lot #: AK9796, Exp. Date 09/2022
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.